Phaco decreases mortality

Article

Contrary to accepted wisdom, cataract surgery decreases mortality rates, according to results published online ahead of print by the British Journal of Ophthalmology.

Contrary to accepted wisdom, cataract surgery in fact decreases mortality rates, according to results published online ahead of print by the British Journal of Ophthalmology.

Michael SJ Blundell of the Academic Unit of Ophthalmology at the University of Bristol and Bristol Eye Hospital, UK and colleagues collated survival data from patients undergoing cataract surgery between December 2000 and February 2001 (n=933) and compared them with national and regional mortality rates.

The team determined that the patients who had undergone the phaco procedure had a statistically significant reduced rate of mortality when compared with either national or regional rates.

As this result is in contrast to the post-phaco increased mortality rate established in earlier studies, the researchers recommend further investigation and evaluation in this field.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.